ACADIA PHARMACEUTICALS

Company

ACADIA PHARMACEUTICALS INC

Filed

January 21, 2011

Accession Number

0001072613-11-000046

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →